Matt Ellis
Chair of Prostate Cancer Research

Matt was a member of the Board of Trustees for Prostate Cancer Research in 2016 and was the Chair between 2018-2024. He has just taken on a new role of Chair of Trustees for Kidney Research UK.

Matt is also a Director of Cambridge spin-out Constructive Bio, whose platform technologies allow the fundamental reprogramming of the genetic code to create new classes of enzymes, pharmaceuticals and biomaterials.

Prior to this, Matt worked in investment banking for 15 years, advising on over $300bn of M&A transactions and over $3bn of equity fundraising for some of the largest companies in the UK.